Presented by:

Morgan T. Sammons

Sponsored by:

Canadian Psychological Association

Continuing Education Credits:

6

Notes:

Cost:

CPA Member: Early Registration ($250+tax) - Regular Registartion ($300+tax)

CPA Student Affiliate: Early Registration ($190+tax) - Regular Registartion ($225+tax)

Non-Member: Early Registration ($325+tax) - Regular Registartion ($400+tax)

Student Non Affiliate: Early Registration ($230+tax) - Regular Registartion ($250+tax) 

Please note: early registration (until end-of-day April 30th, 2019) and regular registration (after April 30th, 2019)

Duration:

Full Day (9:00 – 16:30)

Target Audience:

Clinicians and graduate students.

Skill/Difficulty Level:

Intermediate

Workshop Description:

This 6-hour continuing education presentation will address recent developments in clinical psychopharmacology and how such developments affect the practice of psychologists. Newly introduced drugs will be covered along with a survey of agents in the following classes: antidepressants, anxiolytics, antipsychotics, mood stabilizers, and psychostimulants. Characteristics of commonly used drugs, their indications, mechanisms of action and common clinical uses will be discussed, along with techniques for combining pharmacological and nonpharmacological treatments. The evidence base supporting the use of common psychotropics will be addressed along with optimal treatment strategies.

Learning Outcomes:

1. Attendees will appreciate the most recent research regarding properties of frequently used pharmacological agents, including efficacy, side effects, and contraindications
2. Attendees will understand the latest evidence supporting the combination of drug and non-drug treatment for common mental disorders
3. Attendees will understand basics of clinical utilization of common psychotropic drugs, including initiation and discontinuation strategies and techniques for minimizing adverse side effects